High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker

Heart and Vessels

Volumn 23, Issue 6, 2008, Pages 390-396

  Jha, Hem Chandra ^a   Prasad, Jagdish ^b   Mittal, Aruna ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Cytomegalovirus; Immunoglobulin G; Inflammatory markers; Risk factors; Serology

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN A;

ALCOHOLISM; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FAMILY HISTORY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY ANALYSIS; SEROLOGY; SMOKING;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, BACTERIAL; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; INDIA; MALE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 57149106354     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1062-9     Document Type: Article

References (38)

1. Higgins JP (2003) Chlamydia pneumoniae and coronary artery disease: The antibiotic trials. Mayo Clin Proc 78:321-332
2. Bulliyya G (2000) Key role of dietary fats in coronary heart disease under progressive urbanization and nutritional transition. Asia Pacific J Clin Nutr 9(4):289-297
3. Deedwania P, Singh V (2005) Coronary artery disease in South Asians: evolving strategies for treatment and prevention. Indian Heart J 57:617-631
4. Jose VJ, Gupta SN (2004) Mortality and morbidity of acute ST segment elevation myocardial infarction in the current era. Indian Heart J 56:210-214
5. Rissa HS, Kishor S, Trehan N (2001) Coronary artery disease in young Indians - the missing link. J Indian Acad Clin Med 2(3): 128-132
6. Enas AE, Annamalai SK (2001) Coronary artery disease in Asian Indians: an update and review. Internet J Cardiol 1(2)
7. Vojdani A (2003) A look at infectious agents as a possible causative factor in cardiovascular disease: Part I. Lab Med 34(3): 203-212
8. Fong I W (2000) Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 163(1): 49-56
9. Cunningham P (2000) Is coronary artery disease an infectious disease? J Inform Pharmacother 2:320-325
10. Sheehan J, Kearney PM, Sullivan SO, Mongan C, Kelly E, Perry IJ (2005) Acute coronary syndrome and chronic infection in the Cork coronary care case-control study. Heart 91:19-22
11. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J (2002) Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105:15-21
12. LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G, Sood S, DeGraba TJ (2001) Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 32:855-860
13. DeGraba TJ (2004) Immunogenetic susceptibility of atherosclerotic stroke implications on current and future treatment of vascular inflammation. Stroke 35(I):2712-2719
14. Campbell LA, Kuo CC, Grayston JT (1998) Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 4(4): 571-579
15. Otsui K, Inoue N, Shiraki SKR, Honjo T, Hirata MTK, Yokoyama SKM (2007) Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries. Heart Vessels 22:416-422
16. Johnston SC, Messina LM, Browner WS, Lawton MT, Morris C, Dean D (2001) C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 32:2748-2752
17. Chen M, Chen C, Wu CYC, Fang C, Chang YHH (2007) Interleukin-18: A strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart Vessels 22:371-375
18. Jha HC, Vardhan H, Gupta R, Varma R, Prasad J, Mittal A (2007) Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern. BMC Infect Dis 7:48
19. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, Quyyumi AA (2002) Predisposition to atherosclerosis by infections role of endothelial dysfunction. Circulation 106:184-190
20. Hermann C, Graf K, Groh A, Straube E, Hartung T (2002) Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 40(5):1603-1609
21. Uter W, Stock C, Pfahlberg A, Guillen-Grima F, Aguinaga-Ontoso I, Brun-Sandiumenge C, Kramer A (2003) Association between infections and signs and symptoms of "atopic" hypersensitivity - results of a cross-sectional survey among first year university students in Germany and Spain. Allergy 58(7):580-584
22. Miller D, Espinosa-Heidmann D, Legra J, Dubovy S, Suner I, Sedmak D, Dix R, Cousins S (2004) The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 138(3):323-328
23. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: Application to clinical and public heAlth practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
24. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J (2001) Chronic infections and the risk of carotid atherosclerosis. Circulation.103:1064-10
25. Ossewaarde JM, Feskens EJM, Vries ADE, Vallinga CE, Kromhout D (1998) Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 120:93-99
26. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes Silva M, Ward M (2000) Chlamydia pneumoniae IgG titers and coronary heart disease: Prospective study and meta analysis. BMJ 321:208-213
27. LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G, Sood S, DeGraba TJ (2001) Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 32:855-860
28. Schumacher A, Lerkerod AB, Seljeflot I, Sommervoll L, Holme I, Otterstad JE, Arnesen H (2001) Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 39:1859-1864
29. Persson K, Boman J (2000) Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol 7:739-744
30. Adiloglu AK, Can R, Nazli C, Ocal A, Ergene O, Tinaz G, Kisioglu N (2005) Ectasia and severe atherosclerosis. Tex Heart Inst J 32:21-27
31. Yamaoka-Tojo M, Tojo T, Machida TMY, Kitano Y, Izumi TKT (2003) C-reactive protein-induced production of interleukin-18 in human endothelial cells: A mechanism of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels 18:183-187
32. Arroyo-Espliguero R, Avanzas P, Cossin-Sales J, Aldama G, Pizzi C, Kaski JC (2004) C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 25:401-408
33. Haidari M, Javadib E, Sadeghia B, Hajilooia M, Ghanbili J (2001) Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem 34(4):309-315
34. Huittinen T, Leinonen M, Tenkanen L, Virkkunen H, Mänttäri M, Palosuo T, Manninen V, Saikku P (2003) Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 107:2566-2570
35. Kiechl S, Werner P, Egger G, Oberhollenzer F, Mayr M, Xu Q, Poewe W, Willeit J (2002) Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis. Stroke 33: 2170-2176
36. Kiechl S, Willeit J, Rungger G, Egger G, Oberhollenzer F, Bonora E (1998) Alcohol consumption and atherosclerosis: What is the relation? Stroke 29:900-927
37. Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB, Willett WC, Manson JE (2000) Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 102:494-499
38. Ghiselli G, Chen J, Kaou M, Hallak H, Rubin R (2003) Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 23:1808-1813